SEC Form 4 · accession 0001209191-15-061229
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William D. Waddill
Officer — SR. VP & CFO
Period of report
Jul 14, 2015
Accepted (ET)
Jul 16, 2015 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 14, 2015 | M | 13,125 | $2.64 | A | 15,625 | D | |
| Common StockF2 | holding | — | — | — | 16,172 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $2.64 | Jul 14, 2015 | M | 13,125 | D | — | Apr 14, 2024 | Common Stock | 13,125 | 61,880 | D |
Explanation of responses
- F1Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on May 15, 2015.
- F2Shares are held directly by William and Katherine Waddill Trust Dated July 26, 2000, of which Reporting Person is a Trustee.
- F31/48 of the Option vests in equal monthly installments one month from 4/1/2014. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.